AV
Avecho Biotechnology Limited
AVEFF · OTC
$0.00 +0.00% (+$0.00)
Market Cap $19.5M
P/E Ratio -
Div. Yield -
ROE 233.64%
Bulios Fair Price
$0
100.0% downside
Current Price
$0.0045
Undervalued Fair Value Overvalued
According to Bulios Fair Price, AVEFF is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
4/9Valuation
42 /100
Fair P/B 12.52x
P/FCF 17.71x
P/S 15.78x
Growth
19 /100
Declining Book val. growth 13.69%
Rev. growth 0.86%
FCF growth N/A
Profitability
50 /100
Moderate Net margin 356.82%
Op. margin 485.09%
FCF margin 89.12%
Quality
2 /100
Poor ROE 233.64%
ROA 62.15%
Asset turnover 0.17x
Debt
69 /100
Low Current ratio 9.95x
Int. coverage -13.01x
Debt/Equity 0.01x
Stability
19 /100
Unstable Rev. volatility 122.12%
EPS volatility 129.91%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about AVEFF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Paul Gavin
Employees
15
Headquarters
Clayton
Upcoming events
03 MAR
Earnings
Upcoming earnings report